Skip to main content
[Preprint]. 2024 Sep 27:2024.09.25.614766. [Version 1] doi: 10.1101/2024.09.25.614766

Figure 1. IP-FCM to detect mHTT and comparison of assay with Singulex approach.

Figure 1.

A. IP-FCM assay workflow to detect mHTT in biofluid samples. B. Head-to-head comparison of IP-FCM with Singulex mHTT detection assay approaches with the same biofluid sample set from control, premanifest, and manifest HD participants shows good agreement of the methodologies. R-squared and p-values calculated from simple linear regression analysis.